Literature DB >> 1419801

Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.

W E Terpstra1, H M Lokhorst, F Blomjous, O J Meuwissen, A W Dekker.   

Abstract

In 54 patients with multiple myeloma plasma cell infiltration was compared in bone marrow biopsies and aspirates. In 48% of cases plasma cell infiltration was comparable, in 48% infiltration in the aspirate was lower than in the biopsy. In only two cases more plasma cells were found in the aspirate. Eleven patients (20%) had less than 20% plasma cells in the aspirate and more than 50% in the biopsy. Underestimation of plasma cell load especially seems to occur in patients with a focal growth pattern of multiple myeloma or when strong fibrosis is present. 69% of patients with stage III, according to Durie & Salmon (1975), and 76% of patients with a high beta 2-microglobulin had more than 50% plasma cells in the biopsy, indicating that these parameters, which are based on tumour load, are influenced by other factors as well. The bone marrow biopsy is of superior value for direct estimation of the tumour load in multiple myeloma compared to bone marrow aspirates. A prospective study is needed to determine its prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419801     DOI: 10.1111/j.1365-2141.1992.tb04592.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.

Authors:  Samer Z Al-Quran; Lijun Yang; James M Magill; Raul C Braylan; Vonda K Douglas-Nikitin
Journal:  Hum Pathol       Date:  2007-08-21       Impact factor: 3.466

2.  Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling.

Authors:  Vernon Wu; Erin Moshier; Siyang Leng; Bart Barlogie; Hearn Jay Cho; Sundar Jagannath; Deepu Madduri; Madhu Mazumdar; Samir Parekh; Ajai Chari
Journal:  Blood Adv       Date:  2018-06-26

Review 3.  What we mean when we talk about MRD in myeloma. A review of current methods. Part 1 of a two-part series.

Authors:  Scott Ely; Noa Biran; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

4.  Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.

Authors:  Scott A Ely; Daniel M Knowles
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.

Authors:  Shashirekha Shetty; Marion Siady; Kalyan C Mallempati; Andrew Wilson; Jeff Poarch; Brandon Chandler; Judy Gray; Mohamed E Salama
Journal:  Int J Hematol       Date:  2012-02-11       Impact factor: 2.490

6.  Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.

Authors:  Sanja Stifter; Emina Babarović; Toni Valković; Irena Seili-Bekafigo; Christophe Stemberger; Antica Nacinović; Ksenija Lucin; Nives Jonjić
Journal:  Diagn Pathol       Date:  2010-05-18       Impact factor: 2.644

7.  Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

Authors:  Madhav V Dhodapkar; Rachael Sexton; Sarah Waheed; Saad Usmani; Xenofon Papanikolaou; Bijay Nair; Nathan Petty; John D Shaughnessy; Antje Hoering; John Crowley; Robert Z Orlowski; Bart Barlogie
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

8.  Pancytopenia in Multiple Myeloma- An Enigma: Our Experience from Tertiary Care Hospital.

Authors:  Hanaganahalli B Sridevi; Sharada Rai; Pooja K Suresh; Meludurgamutt S Somesh; Jessica Minal
Journal:  J Clin Diagn Res       Date:  2015-11-01

9.  Pancytopenia: a clinico hematological study.

Authors:  B N Gayathri; Kadam Satyanarayan Rao
Journal:  J Lab Physicians       Date:  2011-01

10.  Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response.

Authors:  Svitlana Demyanets; Alexandra Kaider; Ingrid Simonitsch-Klupp; Günther Bayer; Almira Subasic; Renate Thalhammer; Harald Esterbauer; Maria T Krauth; Hermine Agis; Thomas Reiter; Ilse Schwarzinger
Journal:  Ann Hematol       Date:  2020-09-15       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.